View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 18, 2020

Covid-19: GeaCom to deploy devices for virus triage and management

US-based GeaCom is set to deploy its Phrazer/Kitsune devices to be used for the triage and management of coronavirus (Covid-19).


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Follow the latest updates of the outbreak on our timeline.


US-based GeaCom is set to deploy its Phrazer/Kitsune devices to be used for the triage and management of coronavirus (Covid-19).

GeaCom has deployed its devices to meet the growing demand in regional response centres throughout the Upper Midwest.

Using Phrazer/Kitsune devices, medical centres can manage patient intake by allowing self-triage in any language. They identify and match the patient’s language, culture and literacy and allow them to conduct screening through an authoritative on-site solution.

Furthermore, the devices help hundreds of patients to simultaneously progress to suitable rooming and isolation, without exposing translators, scribes and other hospital staff to the virus.

GeaCom founder and CEO Mat Johnson said: “Phrazer/Kitsune is a vital tool for keeping medical staff safe during the screening process and it mitigates the spread of the virus.

“GeaCom has been preparing to help the health care system combat this global crisis, and the thousands of Phrazer/Kitsune devices ready for deployment have the potential to equitably address the entire population and accelerate the processing rate by tenfold at regional response centres.”

Alerts from Phrazer/Kitsune will keep medical staff constantly aware of patient’s needs, while they self-triage and progress through Covid-19 services.

The devices allow clinicians to remotely engage with patients and securely check in on them through a video conference.

Phrazer/Kitsune devices are antimicrobial, HIPPA-compliant and intrinsically safe systems, which can be cleaned with strong chemicals.

In addition, the devices can operate with or without a network and its video conference function enables constant patient surveillance and support.

The global death toll due to Covid-19 has increased to 7,900.

Covid-19 has now spread to 167 countries.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network